Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00301119 · ClinicalTrials.gov registry record
Lung Cancer Biomarkers and Screening
A clinical trial of Lung Cancer, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 10,850
- Enrollment target
- 1
- Study location
NCT00301119 is a study of Lung Cancer that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 10,850 participants, above the 909-participant average among 409 other Lung Cancer trials with a reported enrollment target (1094% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00301119, a study of Lung Cancer, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 10,850 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
Conditions Studied
Study Locations (1)
New York
- NYU Cancer Institute at New York University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,850 participants |
| Start Date | 2000-05 |
| Est. Completion | 2030-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00301119
The ClinicalTrials.gov registry entry for NCT00301119 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,850 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 909-participant average among 409 other Lung Cancer trials with a reported enrollment target (1094% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00301119 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00301119 about?
NCT00301119 is a clinical study titled "Lung Cancer Biomarkers and Screening". RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
What is the current status of trial NCT00301119?
This trial is currently recruiting. The enrollment target is 10,850 participants. The study started on 2000-05. Estimated completion is 2030-05.
What conditions does trial NCT00301119 study?
This clinical trial studies the following conditions: Lung Cancer.
Who is sponsoring clinical trial NCT00301119?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00301119 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.